Delivery Order SPE2DB20D3103-SPE2DB25FM4X2

Award Date 1/28/25
Potential Completion Date 2/19/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Envarsus XR 1 mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,677.52 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 27, 2024. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of Envarsus XR 1 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,216.11, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31,...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a Firm Fixed Price of $3,230.68. The contract has an ultimate completion date of August 5, 2024 and was awarded on July 15, 2024. This award is a Delivery Order issued under Amerisourcebergen's...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The specific award is a $3,230.68 firm...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Envarsus XR 4 mg tablets. The $1,615.33 firm fixed-price delivery order has an ultimate completion date of October 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This federal contract award is a delivery order (SPE2DX15D1053|SPE2DX24F6TDK) from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, for the supply of Envarsus XR 1 mg tablets. The contract has a firm fixed price of $1,216.11 and a completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support military treatment programs and...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $5,271.58 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 7, 2022, with a completion date of July 28, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,216.11 fixed-price delivery order is for the supply of 4,565,469,346 units of the prescription medication Envarsus XR 1 mg tablet. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded numerous federal contracts to supply a wide...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Envarsus XR 1 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $1,465.68 with a completion date of September 9, 2024. The contract has no set-aside designation. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of ENVARSUS XR 0.75 MG tablets to the Defense Logistics Agency (DLA). The $1,141.80 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM4X2
    Delivery Order

This federal contract award is for the provision of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA). The $1,288.86 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 19, 2025 and was awarded on January 28, 2025. No set-aside designation was used for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/29/25, 9:57 AM